Ratings by Jefferies (Young Li)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | Accuray | ARAY | Downgrade | Hold (Buy) |
0.38 (0.32) |
-15.79% | Details | |
| 1/13/2026 | RxSight Inc. | RXST | Maintain | Hold (N/A) |
|
Details | ||
| 10/13/2025 | TransMedics Group | TMDX | New Coverage | Buy (N/A) |
112.98 (77.59) |
-31.32% | Details | |
| 7/10/2025 | RxSight Inc. | RXST | Downgrade | Hold (Buy) |
12.79 (5.25) |
-58.95% | Details | |
| 3/18/2025 | Hyperfine Inc. | HYPR | Maintain | Hold (N/A) |
|
Details | ||
| 3/7/2025 | Cooper Companies | COO | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2025 | RxSight Inc. | RXST | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2024 | RxSight Inc. | RXST | New Coverage | Buy (N/A) |
50.38 (12.79) |
-74.61% | Details | |
| 7/16/2024 | Cooper Companies | COO | Upgrade | Buy (Hold) |
90.81 (70.17) |
-22.73% | Details | |
| 5/14/2024 | Hyperfine Inc. | HYPR | Downgrade | Hold (Buy) |
0.80 (1.48) |
85% | Details | |
| 4/9/2024 | Hyperfine Inc. | HYPR | Maintain | Hold (N/A) |
|
Details | ||
| 11/30/2023 | Hyperfine Inc. | HYPR | New Coverage | Hold (N/A) |
1.20 (1.48) |
23.33% | Details | |
| 4/17/2023 | ViewRay Inc. | VRAY | Downgrade | Hold (Buy) |
1.83 (0.03) |
-98.36% | Details | |
| 11/2/2022 | ViewRay Inc. | VRAY | New Coverage | Buy (N/A) |
4.40 (0.03) |
-99.32% | Details |
